Linked Life Data

7725260

Source:http://linkedlifedata.com/resource/pubmed/id/7725260

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-5-19
pubmed:abstractText
Patients and medical personnel of some hemodialysis centres of the north-west region of the Russian Federation were examined for HB-virus infection markers using enzyme immunoassays. Subjects free of HB markers were immunized with ENGEPIX-B vaccine. Immunogenicity of the vaccine was assessed one month and one year after the immunization. Epidemiological HB factors in hemodialysis centers were studied on the simulation computer model. HB-virus-containing blood transfusion factor is not the only determinant of HB-virus infection prevalence. The virus can be transmitted via hemodialysis facilities. Immunization effects proved inferior in the hemodialysis unit patients. It is stated that vaccinoprophylactic policy in the patients of the dialysis centers and relevant equipment need serious improvement to prevent hepatitis B outbreaks.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0040-3660
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
47-51
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[The characteristics of the prevention of HB viral infection in hemodialysis units].
pubmed:publicationType
Journal Article, English Abstract